Page last updated: 2024-09-05

sorafenib and pik 75

sorafenib has been researched along with pik 75 in 2 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(pik 75)
Trials
(pik 75)
Recent Studies (post-2010) (pik 75)
6,5207305,25135031

Protein Interaction Comparison

ProteinTaxonomysorafenib (IC50)pik 75 (IC50)
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoformHomo sapiens (human)0.91
Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit betaHomo sapiens (human)0.2476
Cyclin-T1Homo sapiens (human)0.0014
Receptor-type tyrosine-protein kinase FLT3Homo sapiens (human)0.0052
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoformHomo sapiens (human)0.1256
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoformHomo sapiens (human)0.2661
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)0.2476
Glycogen synthase kinase-3 betaHomo sapiens (human)0.009
Cyclin-dependent kinase 9Homo sapiens (human)0.0014
D(2) dopamine receptorRattus norvegicus (Norway rat)0.34

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Beck, ME; Braun, CA; Getlik, M; Grütter, C; Gutbrod, O; Mayer-Wrangowski, SC; Pérez-Martín, J; Rauh, D; Richters, A; Schreier, PH; Simard, JR1
Bharate, SB; Raghuvanshi, R1

Other Studies

2 other study(ies) available for sorafenib and pik 75

ArticleYear
Targeting GSK3 from Ustilago maydis: type-II kinase inhibitors as potential antifungals.
    ACS chemical biology, 2012, Jul-20, Volume: 7, Issue:7

    Topics: Amino Acid Sequence; Antifungal Agents; Crystallography, X-Ray; Drug Delivery Systems; Glycogen Synthase Kinase 3; Humans; Molecular Sequence Data; Protein Kinase Inhibitors; Ustilago

2012
Recent Developments in the Use of Kinase Inhibitors for Management of Viral Infections.
    Journal of medicinal chemistry, 2022, 01-27, Volume: 65, Issue:2

    Topics: Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Drug Approval; Drug Repositioning; High-Throughput Screening Assays; Humans; Protein Kinase Inhibitors; SARS-CoV-2; United States; United States Food and Drug Administration; Virus Diseases

2022